MMS R&D Engineering Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

BD · 12 hours ago

MMS R&D Engineering Intern

BD is one of the largest global medical technology companies in the world, focused on advancing health. The internship program provides students with hands-on experience in the development of infusion products and exposure to the medical device industry.

Health CareMedical DeviceTechnical Support
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Assist in the development of infusion products while giving students corporate experience in R&D
Partner with peers, senior personnel, and supervisors who will provide informal mentoring and coaching towards success
Be exposed to the process of designing and developing medical device products for different global markets
Work within cross-functional or interdisciplinary teams and may have multiple internal partners and customers
Develop technical engineering expertise through an individual project
Build hands-on laboratory skills and deliver business presentations showcasing their work

Qualification

Engineering degreeLaboratory skillsTeam collaborationProblem-solvingPresentation skills

Required

BS and/or MS/PhD student pursuing a degree in Engineering

Benefits

A valuable, competitive package of compensation and benefits programs
Rewards and recognition opportunities that promote a performance-based culture

Company

BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.

H1B Sponsorship

BD has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (66)
2022 (4)
2021 (3)

Funding

Current Stage
Public Company
Total Funding
$540M
Key Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO

Leadership Team

leader-logo
Tom Polen
Chairman, CEO and President
linkedin
leader-logo
Richard Byrd
Executive Vice President and President of the BD Interventional Segment
linkedin
Company data provided by crunchbase